|By PR Newswire||
|April 7, 2014 07:00 AM EDT||
SEATTLE, April 7, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at the 13th Annual Needham Healthcare Conference in New York later this week. The presentation is scheduled for Wednesday, April 9, 2014 at 3:00 p.m. EDT.
The presentation will be webcast. The live and archived webcasts can be accessed on the "Events" page of the Company's website at www.omeros.com.
About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics targeting inflammation, coagulopathies and disorders of the central nervous system. Derived from its proprietary PharmacoSurgery® platform, the Company's lead drug product, Omidria™ (OMS302) for lens replacement surgery, is currently under review for marketing approval by both the US Food and Drug Administration and the European Medicines Agency with US commercial launch planned for the second half of 2014. Omeros' six other clinical programs are focused on schizophrenia, Huntington's disease and cognitive impairment; addictive and compulsive disorders; complement-related diseases; and preventing problems associated with surgical procedures. Omeros also has a proprietary GPCR platform, which is making available an unprecedented number of new GPCR drug targets and corresponding compounds to the pharmaceutical industry for drug development.
SOURCE Omeros Corporation
Sep. 25, 2016 06:15 PM EDT Reads: 2,389
Sep. 25, 2016 05:30 PM EDT Reads: 1,535
Sep. 25, 2016 05:15 PM EDT Reads: 1,516
Sep. 25, 2016 05:00 PM EDT Reads: 1,742
Sep. 25, 2016 04:15 PM EDT Reads: 2,550
Sep. 25, 2016 03:15 PM EDT Reads: 4,384
Sep. 25, 2016 03:00 PM EDT Reads: 1,574
Sep. 25, 2016 02:30 PM EDT Reads: 1,509
Sep. 25, 2016 02:00 PM EDT Reads: 2,602
Sep. 25, 2016 02:00 PM EDT Reads: 1,514
Sep. 25, 2016 01:00 PM EDT Reads: 827
Sep. 25, 2016 12:45 PM EDT Reads: 2,457
Sep. 25, 2016 12:15 PM EDT Reads: 1,112
Sep. 25, 2016 12:15 PM EDT Reads: 3,380
Data is an unusual currency; it is not restricted by the same transactional limitations as money or people. In fact, the more that you leverage your data across multiple business use cases, the more valuable it becomes to the organization. And the same can be said about the organization’s analytics. In his session at 19th Cloud Expo, Bill Schmarzo, CTO for the Big Data Practice at EMC, will introduce a methodology for capturing, enriching and sharing data (and analytics) across the organizati...
Sep. 25, 2016 11:45 AM EDT Reads: 1,646